Understanding The Role of ARHGEF17: Potential Drug Targets (G9828)

Target Name: ARHGEF17

NCBI ID: G9828

Understanding The Role of ARHGEF17: Potential Drug Targets

ARHGEF17 (P164RHOGEF) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a critical role in cellular signaling.

One of the unique features of ARHGEF17 is its structure. It is a 17-kDa protein that consists of an extracellular region, a transmembrane region, and an intracellular region. The extracellular region consists of a singleton transmembrane protein (SM), which contains a catalytic center and a regulatory domain. The transmembrane region consists of four transmembrane domains: an N-terminal alpha-helices domain, a beta-helices domain, a gamma-helices domain, and a delta-helices domain. The intracellular region consists of a single transmembrane protein (TM) that contains a catalytic center and a regulatory domain.

The function of ARHGEF17 is not well understood, but it is believed to play a role in intracellular signaling. It is involved in several signaling pathways, including the regulation of ion channels, protein activation, and cell survival.

One of the potential drug targets for ARHGEF17 is the use of small molecules. Many small molecules have been shown to interact with ARHGEF17 and to modulate its function. For example, several studies have shown that inhibitors of the kinase PDK4 can reduce the activity of ARHGEF17 and its downstream targets. Similarly, inhibitors of the phosphatidylinositol (PI) signaling pathway have also been shown to inhibit the activity of ARHGEF17.

Another potential drug target for ARHGEF17 is the use of monoclonal antibodies (mAbs). MAbs are laboratory-produced antibodies that can be used to specifically bind to ARHGEF17 and to modulate its function. Many studies have shown that mAbs can be used to block the activity of ARHGEF17 and its downstream targets, and that this can be a useful tool for studying the function of this protein.

In conclusion, ARHGEF17 is a protein that is expressed in various tissues throughout the body and is involved in several signaling pathways. Its function is not well understood, but it is thought to play a role in intracellular signaling. There is ongoing research into the potential drug targets for ARHGEF17, including the use of small molecules and mAbs. Further studies are needed to fully understand the role of this protein and its potential as a drug target.

Protein Name: Rho Guanine Nucleotide Exchange Factor 17

Functions: Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPases

More Common Targets